UroGen Pharma Ltd. (URGN)
28.89
-0.99
(-3.31%)
USD |
NASDAQ |
May 22, 16:00
28.87
-0.02
(-0.07%)
After-Hours: 20:00
UroGen Pharma Market Cap : 1.408B for May 22, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Cogent Biosciences, Inc. | 5.582B |
| BioCryst Pharmaceuticals, Inc. | 2.107B |
| United Therapeutics Corp. | 24.13B |
| Puma Biotechnology, Inc. | 360.37M |
| TG Therapeutics, Inc. | 5.950B |
Market Cap Related Metrics
| PS Ratio | 9.990 |
| Price | 28.89 |
| Earnings Yield | -9.54% |